Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001193125-26-047537

Director acquired 129,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bruno Julianne Director 2026-02-09 Option exercise +129,000 137,032 D
Derivatives
Bruno Julianne Director 2026-02-09 Option exercise · Series C Preferred Stock −129 0 D
Loading xslF345X05/ownership.xml…